Nabriva Therapeutics Plc (NBRV)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.4200 unch (unch) 07/31/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.4200 unch (unch) -
for Mon, Jul 31st, 2023
Results
download Want to compare other data? Select Fields| Symbol | NBRV | PRE | FBIO | ||
| Company | Nabriva Therapeutics Plc | Prenetics Global Limited Class A Ordinary Share | Fortress Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.4500 | 5.27 | 1.6500 | ||
| High | 1.9000 | 5.36 | 1.6800 | ||
| Low | 1.3500 | 5.00 | 1.6100 | ||
| Last | 1.4200 | 5.13 | 1.6800 | ||
| Change | unch | +0.13 | +0.0400 | ||
| % Change | unch | +2.60% | +2.44% | ||
| Volume | 717,200 | 9,600 | 64,400 | ||
| 20-Day Average Volume | 46,640 | 9,060 | 194,690 | ||
| Previous Close | 1.4200 | 5.00 | 1.6400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 4.08 | 1.5340 | ||
| 20-Day Raw Stochastic | 12.73% | 89.85% | 97.22% | ||
| 20-Day Relative Strength | 42.54% | 63.82% | 54.60% | ||
| Weighted Alpha | -50.30 | -3.87 | -23.03 | ||
| Today's Opinion | 100% Sell | 8% Sell | 56% Sell | ||
| Previous Opinion | 100% Sell | 8% Sell | 64% Sell | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | +19.30% since 04/21/25 | +12.00% since 04/21/25 | ||
| Low | 1.3500 on 07/31/23 | 4.30 on 04/22/25 | 1.4500 on 04/22/25 | ||
| High | 1.9000 on 07/31/23 | 5.36 on 04/28/25 | 1.6900 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | +28.25% since 03/28/25 | +4.35% since 03/28/25 | ||
| Low | 1.3500 on 07/31/23 | 3.09 on 04/10/25 | 1.3300 on 04/09/25 | ||
| High | 1.9000 on 07/31/23 | 5.36 on 04/28/25 | 1.6900 on 04/25/25 | ||
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | -3.21% since 01/28/25 | -5.88% since 01/28/25 | ||
| Low | 1.3500 on 07/31/23 | 3.09 on 04/10/25 | 1.3300 on 04/09/25 | ||
| High | 2.2400 on 05/19/23 | 5.80 on 02/10/25 | 2.0000 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | +7.55% since 10/28/24 | -16.83% since 10/28/24 | ||
| Low | 1.2600 on 03/27/23 | 3.09 on 04/10/25 | 1.3300 on 04/09/25 | ||
| High | 2.2400 on 05/19/23 | 6.00 on 01/21/25 | 2.3600 on 01/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 46,013 | 44,892 | ||
| Shares Outstanding, K | 32,015 | 12,205 | 29,534 | ||
| Annual Sales | 36,940,000 | 21,740,000 | 57,680,000 | ||
| Annual Net Income | -57,190,000 | -62,720,000 | -46,000,000 | ||
| Last Quarter Sales | 7,590,000 | 7,780,000 | 15,120,000 | ||
| Last Quarter Net Income | -8,700,000 | -10,670,000 | -6,770,000 | ||
| 60-Month Beta | 1.53 | -0.20 | 1.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | -0.84 on 11/27/24 | -0.26 on 03/31/25 | ||
| Latest Earnings Date | 08/02/23 | 06/17/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/17/16 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||